European Consumer

Health Market Trends

A 2024 Q2 Snapshot

© 2024. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States, the European Union, and various other countries.
 General overview

Evolution of the European Consumer Health Market

Overall CH growth driven by the PEC market

Break down of the Consumer Health Market: EUR 100.8bn - MAT Q2 2024 – Public Prices

OTC: 66% +0,8% PEC: 17% +7,9% PAC: 12% -3,8%

NTR: 4% +4,7%

The Key Figures

MAT Q2 2024 – Public Prices

11.8%
+1.5% +3.5% MS of new
MAT Q2 Price rise launches

OTC 0.8% OTC 2.5% OTC 8.8%

PEC 7.9% PEC 6.4% PEC 23.4%
PAC -3.8% PAC 3.7% PAC 9.8%
NTR 4.7% NTR 5.9% NTR 14.3%

The Latest Trends

YTD Q2 2024 – Public Prices

+3.4% +7.2% +0.8% +4.4%

OTC PEC PAC NTR

The Market Dynamics

MAT Q2 2024 – Public Prices
10%
Y axis: Latest MAT growth

8% PEC
6%
NTR
4%

2%
OTC
0%
0.0% 1.0% 2.0% 3.0% 4.0% 5.0% 6.0% 7.0%
-2%

-4% PAC
X axis: CAGR 4 years
-6%

IQVIA CH Global Insights | Newsletter Q2 2024 | Source: IQVIA Consumer Health Customized Insights © 2024. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States, the European Union, and various other
countries. 1
 General overview

Focus on the European e-commerce Analysis based on 11 European countries

PEC also driving e-commerce growth

Break down of the Consumer Health Market - MAT Q2 2024 – Public Prices
Brick & Mortar: 90%
e-Pharmacy: 10% +8,7% +3,8%

The Key Figures

MAT Q2 2024 – Public Prices

12.9%
+8.7% +4.1% MS of new
MAT Q2 Price rise launches

OTC 6.9% OTC 3.2% OTC 9.9%

PEC 16.5% PEC 5.9% PEC 19.7%
PAC -0.6% PAC 1.9% PAC 14.0%
NTR 5.6% NTR 6.6% NTR 23.1%

The Latest Trends

YTD Q2 2024 – Public Prices

+9.2% +16.3% +1.8% +4.9%

OTC PEC PAC NTR

The Market Dynamics

MAT Q2 2024 – Public Prices

12%
Y axis: Latest MAT growth

10%
e-Commerce
8%

6%

4% Brick&Mortar
2%
X axis: CAGR 2 years
0%
0.0% 2.0% 4.0% 6.0% 8.0% 10.0% 12.0% 14.0% 16.0% 18.0%

IQVIA CH Global Insights | Newsletter Q2 2024 | Source: IQVIA Consumer Health Customized Insights
© 2024. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States, the European Union, and var ious other countries. 2
 OTC Market

Evolution of the European OTC Market

A mild winter impacted the overall market growth

Break down of the OTC Market: EUR 66.7bn - MAT Q2 2024 – Public Prices

COUGH COLD&OTH
PAIN RELIEF: DIGESTIVE:
RESP PROD: 22% - All Others: 47% +2,1%
16% +1,2% 15% +4,1%
4,3%

The Key Figures

MAT Q2 2024

8.8%
+0.8% +2.5% MS of new
MAT Q2 Price rise launches

The top 3 Corporations

MAT Q2 2024

In terms of sales (€bn) In terms of growth In terms of innovation

SANOFI 3.2 BALANCE PHARMA 407205% HALEON 3.1%

HALEON 3.0 SHLS PHARMA 361010% SANOFI 3.0%

BAYER 2.3 LINDAREN MED 215760% STADA 2.8%

The Price index

135
130
125
120
115
110
105
100
95
90
Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2
2019 2019 2020 2020 2020 2020 2021 2021 2021 2021 2022 2022 2022 2022 2023 2023 2023 2023 2024 2024

IQVIA CH Global Insights | Newsletter Q2 2024 | Source: IQVIA Consumer Health Customized Insights
© 2024. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States, the European Union, and var ious other countries. 3
 OTC Market

Evolution of the European OTC Market

A mild winter impacted the overall market growth

The top 3 Categories - MAT Q2 2024 – Public Prices

In terms of sales (€M) Growth Avg retail price Leading Corp.

02A1 GENER.PAIN
RELIEF ADULTS
4,842 0.2% € 3.26 +4.04% Sanofi
02E1 MUSC. PAIN
RELIEF (TOP)
2,738 2.4% € 7.22 +0.58% Haleon
01C1 SORE THROAT
REMS.
2,697 -7.0% € 6.05 -1.12% Reckitt Benckiser

The top/down categories in terms of growth - MAT Q2 2024 – Public Prices

• Multivitamins without mineral for • Asthma Remedies: -18.4%

perinatal use: +49.2% • Cold & Flu
• Geriatric prep. With procaine: +26.5% immunostimulants: -20.3%
• H1 Antagonist: +19.5% • Anti-Alcohol: -22.6%

The top/down categories in terms of innovation - MAT Q2 2024 – Public Prices

• Sleeping Products: 5.1% MS • Other Habit Treatments

• General Pain Relief: 4.5% MS • Other Herbal Geriatric
• Probiotics Digestive Health: 4.0% MS preparations
• Anti-Alcohol

IQVIA CH Global Insights | Newsletter Q2 2024 | Source: IQVIA Consumer Health Customized Insights
© 2024. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States, the European Union, and var ious other countries. 4
 PEC Market

Evolution of the European PEC Market

A price increase still the highest one within the CH market but slowing down

Break down of the PEC Market: EUR 17.2bn - MAT Q2 2024 – Public Prices

BEAUTY PRODUCTS FOR UNISEX BEAUTY HAIR PRODUCTS:

All Others: 32% +5,8%
WOMEN: 29% +8,1% PRODUCTS: 26% +9,9% 13% +9,0%

The Key Figures

MAT Q2 2024 – Public Prices

23.9%
+7.9% +6.4% MS of new
MAT Q2 Price rise launches

The top 3 Corporations

MAT Q2 2024 – Public Prices

In terms of sales (€bn) In terms of growth In terms of innovation

L OREAL 2.6 FA. LANGSTEINER 1636380% L OREAL 15.9%

PIERRE FABRE 1.6 GALENIKA 594703% PIERRE FABRE 8.8%

BEIERSDORF 0.6 DRYLOCK 397355% CAUDALIE 4.9%

The Price index

135
130
125
120
115
110
105
100
95
90
85
Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2
2019 2019 2020 2020 2020 2020 2021 2021 2021 2021 2022 2022 2022 2022 2023 2023 2023 2023 2024 2024

IQVIA CH Global Insights | Newsletter Q2 2024 | Source: IQVIA Consumer Health Customized Insights
© 2024. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States, the European Union, and var ious other countries. 5
 PEC Market

Evolution of the European PEC Market

A price increase still the highest one within the CH market but slowing down

The top 3 Categories - MAT Q2 2024 – Public Prices

In terms of sales (€M) Growth Avg retail price Leading Brand

82B5 A-AGE/A-WRINKLE
FAC WOMEN
1,648 7.1% € 32.01 +3.88% Vichy
83F2 SUN SCREENS
FOR ADULTS
1,253 12.8% € 18.92 +4.55% La Roche Posay
83B1 BEAUTY PRDS X
FAMILY USE
842 6.9% € 13.63 +4.06% Cerave

The top/down categories in terms of growth - MAT Q2 2024 – Public Prices

• Adhesives: +332.9% • Epilatories: -20.6%

• Depigmenting Body Products: • Topical Abdominal Fat Reduction
+147.2% Products for Men: -22.1%
• Facial Masks for Men: +146.2% • Pre-epilatory/depilatory products:
-31.6%

The top/down categories in terms of innovation - MAT Q2 2024 – Public Prices

• Anti-wrinkle Facial Women: 14.4% MS • Baby baths

• Sunscreens for Adults: 10.1% MS • Hair Glittes
• Anti-seborrheic Caring Products: • Axillary Towels
3.6% MS

IQVIA CH Global Insights | Newsletter Q2 2024 | Source: IQVIA Consumer Health Customized Insights
© 2024. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States, the European Union, and var ious other countries. 6
 PAC Market

Evolution of the European PAC Market

The PAC market is progressively recovering at the end of Q2 2024

Break down of the PAC Market: EUR 12.3bn - MAT Q2 2024 – Public Prices

TESTS+MEASURING INCONTINENCE CARE

All Others: 46% -1,1%
INSTRUMNT: 27% -16,6% PRDS: 13% +7,3%
ADVANCED DRESSINGS:
14% +7,4%

The Key Figures

MAT Q2 2024 – Public Prices

9.8%
-3.8% +3.7% MS of new
MAT Q2 Price rise launches

The top 3 Corporations

MAT Q2 2024 – Public Prices

In terms of sales (€bn) In terms of growth In terms of innovation

HARTMANN 0.8 GROTEX 472884% ABBOTT 5.8%

ESSITY 0.8 LIEPAJAS SEZ 147643% ANGELINI 5.0%

ABBOTT 0.6 BJOBJ 113042% ESSITY 4.7%

The Price index

115

110

105

100

95

90
Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2
2019 2019 2020 2020 2020 2020 2021 2021 2021 2021 2022 2022 2022 2022 2023 2023 2023 2023 2024 2024

IQVIA CH Global Insights | Newsletter Q2 2024 | Source: IQVIA Consumer Health Customized Insights
© 2024. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States, the European Union, and var ious other countries. 7
 PAC Market

Evolution of the European PAC Market

The PAC market is progressively recovering at the end of Q2 2024

The top 3 Categories - MAT Q2 2024 – Public Prices

In terms of sales (€M) Growth Avg retail price Leading Corp.

56E2 BLOOD GLUCOSE

TESTS
1,874 -3.5% € 19.33 -0.19% Abbott
47A1 BASE TECH ADVAN
DRESSINGS
1,331 5.8% € 31.60 +2.90% Molnlycke
52B5 PULL UP
INCONTINENCE PRD
719 9.4% € 12.94 +1.22% Essity

The top/down categories in terms of growth - MAT Q2 2024 – Public Prices

• Vibrating Pads: +187.7% • Mask accessories: -79.0%

• Other Wound Care Products: • Other Masks: -81.1%
+91.1% • Coronavirus Gene Tests: -84.3%
• Milk extractors – elect. Pump:
+89.0%

The top/down categories in terms of innovation - MAT Q2 2024 – Public Prices

• Coronavirus Antigen. Tests: 15.3% • Plastic Droppers

MS • Bag Covers
• Base Tech. Advanced Dressings: • Large Weighing Scales
8.1% MS
• Baby Disposables: 6% MS

IQVIA CH Global Insights | Newsletter Q2 2024 | Source: IQVIA Consumer Health Customized Insights
© 2024. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States, the European Union, and var ious other countries. 8
 NTR Market

Evolution of the European NTR Market

Inflation continues its downward trend in MAT Q2 2024

Break down of the NTR Market: EUR 4.5bn - MAT Q2 2024 – Public Prices

ENTERAL NUTRITION PRD: All Others: 17%

38% +7,8% BABY FOODS: 33% +4,2% +1,4%
FOOD FOR ADULTS:
11% +1,8%

The Key Figures

MAT Q2 2024 – Public Prices

14.3%
+4.7% +5.9% MS of new
MAT Q2 Price rise launches

The top 3 Corporations

MAT Q2 2024 – Public Prices

In terms of sales (€bn) In terms of growth In terms of innovation

DANONE GROUPE 1.0 ORTHOMEDIX 93167% DANONE GROUPE 22.7%

NESTLE 0.6 ALLNUTRITION 40900% NESTLE 20.9%

FRESENIUS 0.4 MILAPHARM 38833% ABBOTT 4.4%

The Price index

120

115

110

105

100

95
Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2
2019 2019 2020 2020 2020 2020 2021 2021 2021 2021 2022 2022 2022 2022 2023 2023 2023 2023 2024 2024

IQVIA CH Global Insights | Newsletter Q2 2024 | Source: IQVIA Consumer Health Customized Insights
© 2024. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States, the European Union, and var ious other countries. 9
 NTR Market

Evolution of the international NTR Market

Inflation continues its downward trend in MAT Q2 2024

The top 3 Categories - MAT Q1 2024 – Public Prices

In terms of sales (€M) Growth Avg retail price Leading Corp.

35G1 NORMAL MILKS 658 5.2% € 10.27 +4.64% Danone

30A3 HIGH ENERGY
FEEDS
563 5.7% € 14.04 +4.26% Fresenius
32A1 GLUTEN-FREE
PRODUCTS
406 2.7% € 2.89 +1.73% Dr Schaer

The top/down categories in terms of growth - MAT Q2 2024 – Public Prices

• Equip. & Access. For Enteral • Other Drinks for Children: -9.1%
Nutrition: +15.7% • Herbal Drinks for Children: -12.4%
• Nutritional Supplement: +13.9% • Dried meals for Children: -23.8%
• Juices for Adults: + 11.7%

The top/down categories in terms of innovation - MAT Q2 2024 – Public Prices

• Normal Milks: 27.1% MS • Milk Powders

• Nutritional Supplements: 10.7% • Other Drinks for Children
MS • Other Milk products for Children
• High Protein Feeds: 8.4% MS

IQVIA CH Global Insights | Newsletter Q2 2024 | Source: IQVIA Consumer Health Customized Insights
© 2024. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States, the European Union, and var ious other countries. 10
 Glossary
IQVIA Consumer Health
definitions

Consumer Health Market IQVIA Consumer Health

Consumer Health products are by definition non-
coverage
prescription bound products. IQVIA divides the
Consumer Health market into 4 major market Consumer Health Geographies
segments: IQVIA covers more than 40 countries and 70
• Over-the-Counter (OTC): to treat or cure a channels worldwide with the finest level of data
disease (and in some cases to prevent or avoid granularity available. Where possible, IQVIA
a disease) Consumer Health utilise sell-out data which
provides real-time sales with no stocking up
• Personal Care (PEC): beauty and hygiene
peaks. Data is sourced locally and the
products, plus beauty and hygiene accessories
internationalised with standard product attributes
• Patient Care (PAC): materials, tools, etc linked across all countries, single currency with fixed
to health. These products are usually not active exchange rates net of currency fluctuations, and
by themselves but are of some help in a additional international data attributes per market
patients segment. In addition to pharmacies, mass market
• Nutrition (NTR): alimentary products channels can be included in countries where
sales volumes are significant, as well as e-
IQVIA Consumer Health Classification pharmacies. Data is projected to total country or
IQVIA created its own Consumer Health channel, i.e. representative of total universe.
Classification based on the product’s marketing • Europe includes the following countries: Austria,
positioning, consistent and identical worldwide Belgium, Bulgaria, Croatia, Czech Republic,
which allows comparison within and across Estonia, Finland, France, Germany, Greece,
countries. Products are grouped together where Hungary, Ireland, Italy, Latvia, Lithuania,
they compete from a local marketing positioning. Netherlands, Norway Poland, Portugal,
The classification is structured in 4 levels. Romania, Russia, Serbia, Slovakia, Slovenia,
• CHC1/2/3/4: a class part of the IQVIA Spain, Sweden, Switzerland, Turkey and UK.
Consumer Health Classification with the • All available channels for the above-mentioned
indication of its level of classification. Detailed countries have been included in the present
market segments are defined in CHCs. analysis.
Market analysis • Estonia, Ireland, Latvia, Lithuania, Netherlands,
Serbia and UK only cover the OTC market.
• MAT: Moving Annual Total, a cumulative period
of 12 rolling months. • E-Commerce focus includes the following
countries: Czech Republic, Italy, Poland,
• YTD: Year-to-Date, a cumulative period with
Slovakia, Germany, Hungary, Belgium, Bulgaria,
January a the starting point up to the latest
Spain, Sweden and Portugal.
available period as indicated.
For more details about the coverage, please
• Innovation: in this document, new products &
liaise with your IQVIA representative.
line extension launched in the past 36 months.
• Price index: measure of the relative change in
average observed public prices over time from
Q3 2019.
IQVIA CH Global Insights | Newsletter Q2 2024 | Source: IQVIA Consumer Health Customized Insights
© 2024. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States, the European Union, and var ious other countries. 11
 Consumer Health market is moving fast,
stay ahead of the game with
IQVIA Consumer Health Global Insights
Contact us today: [email protected]

© 2024. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States,
the European Union, and various other countries.